X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (20) 20
humans (19) 19
adult (15) 15
male (15) 15
middle aged (14) 14
female (13) 13
hiv infections - drug therapy (11) 11
hiv (9) 9
infectious diseases (9) 9
drug therapy (8) 8
efavirenz (8) 8
human immunodeficiency virus--hiv (8) 8
young adult (8) 8
anti-hiv agents - adverse effects (7) 7
clinical trials (7) 7
patients (7) 7
adolescent (6) 6
analysis (6) 6
double-blind method (6) 6
efficacy (6) 6
hiv-1-infected patients (6) 6
nitriles - adverse effects (6) 6
nnrti (6) 6
pharmacology & pharmacy (6) 6
pyrazoles - adverse effects (6) 6
treatment outcome (6) 6
aged (5) 5
anti-hiv agents - administration & dosage (5) 5
dose-response relationship, drug (5) 5
health aspects (5) 5
health policy & services (5) 5
hiv infection (5) 5
immunology (5) 5
lersivirine (5) 5
nitriles - administration & dosage (5) 5
pyrazoles - administration & dosage (5) 5
safety (5) 5
acquired immune deficiency syndrome--aids (4) 4
adherence (4) 4
adults (4) 4
anti-hiv agents - therapeutic use (4) 4
antiretroviral drugs (4) 4
antiviral agents (4) 4
drug administration schedule (4) 4
health care sciences & services (4) 4
hiv infections - virology (4) 4
hiv-1 - drug effects (4) 4
pediatrics (4) 4
quality-of-life (4) 4
research (4) 4
reverse-transcriptase inhibitor (4) 4
studies (4) 4
trial (4) 4
abdomen (3) 3
abridged index medicus (3) 3
aids/hiv (3) 3
anidulafungin (3) 3
antiretroviral therapy (3) 3
care and treatment (3) 3
cd4 lymphocyte count (3) 3
cross-over studies (3) 3
dosage and administration (3) 3
double-blind (3) 3
drug combinations (3) 3
drug dosages (3) 3
drug interactions (3) 3
drug resistance (3) 3
drug therapy, combination (3) 3
emtricitabine (3) 3
etravirine (3) 3
highly active antiretroviral therapy (3) 3
hiv-1 (3) 3
hospitals (3) 3
infections (3) 3
internal medicine (3) 3
management (3) 3
maraviroc (3) 3
medical research (3) 3
medicine, experimental (3) 3
microbiology (3) 3
nitriles - pharmacokinetics (3) 3
patient-reported outcome (3) 3
pharmacokinetics (3) 3
pyrazoles - pharmacokinetics (3) 3
reverse transcriptase inhibitors - administration & dosage (3) 3
reverse transcriptase inhibitors - pharmacology (3) 3
reverse transcriptase inhibitors - therapeutic use (3) 3
surgery (3) 3
surveys and questionnaires (3) 3
tenofovir (3) 3
uk-453,061 (3) 3
viral load (3) 3
virology (3) 3
abscess (2) 2
active antiretroviral therapy (2) 2
adenine - analogs & derivatives (2) 2
age (2) 2
aged, 80 and over (2) 2
aids (2) 2
anti-hiv agents - pharmacokinetics (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9993, pp. 552 - 561
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 3/2010, Volume 201, Issue 6, pp. 803 - 813
Background. The MERIT (M̄araviroc versus Ēfavir̄enz īn T̄reatment-Naive Patients) study compared maraviroc and efavirenz, both with zidovudine-lamivudine, in... 
HIV/AIDS | Tropisms | RNA | HIV | Stock options | Response rates | Viruses | Infections | Post hoc | HIV 1 | Virology | INFECTIOUS DISEASES | EFFICACY | SAFETY | MICROBIOLOGY | HIV-1-INFECTED PATIENTS | IMMUNOLOGY | LOPINAVIR-RITONAVIR | THERAPY | VIROLOGICAL FAILURE | RESISTANT HIV-1 | INHIBITOR | CORECEPTOR TROPISM | PLUS | Anti-HIV Agents - pharmacology | Lamivudine - administration & dosage | Cyclohexanes - pharmacology | Humans | Middle Aged | Drug Resistance, Viral | Male | Anti-HIV Agents - standards | Viral Load | Zidovudine - administration & dosage | Young Adult | Cyclohexanes - therapeutic use | Receptors, CCR5 - metabolism | HIV-1 - physiology | Adult | Female | Triazoles - standards | Viral Tropism | Drug Therapy, Combination | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Antiviral Agents - pharmacology | Double-Blind Method | HIV-1 - drug effects | Treatment Outcome | Anti-Retroviral Agents | Benzoxazines - standards | Benzoxazines - therapeutic use | Triazoles - pharmacology | Adolescent | Benzoxazines - pharmacology | Cyclohexanes - standards | HIV Infections - drug therapy | Aged | Drug Combinations | Maraviroc | Patient outcomes | Physiological aspects | Dosage and administration | Genetic aspects | Research | Drug therapy, Combination | Drug therapy | HIV infection | Efavirenz | Chemokines
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2008, Volume 359, Issue 14, pp. 1442 - 1455
In key subgroups of the HIV-infected patients in the MOTIVATE 1 and MOTIVATE 2 studies, a consistent treatment benefit of maraviroc over placebo was seen at 48... 
CCR5 ANTAGONIST | MEDICINE, GENERAL & INTERNAL | EFFICACY | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | ACTIVE ANTIRETROVIRAL THERAPY | DRUG-RESISTANT HIV-1 | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | HEPATITIS-C | PROGNOSTIC VALUE | Triazoles - adverse effects | Humans | Middle Aged | Receptors, CCR5 - genetics | Male | RNA, Viral - blood | Hepatitis B - blood | Viral Load | Hepatitis B - complications | Cyclohexanes - therapeutic use | HIV Infections - immunology | Ethnic Groups | HIV Envelope Protein gp41 - therapeutic use | HIV-1 - chemistry | Hepatitis C - blood | Adult | Female | Hepatitis C - complications | Cyclohexanes - adverse effects | Drug Therapy, Combination | Odds Ratio | CCR5 Receptor Antagonists | Triazoles - therapeutic use | Anti-Retroviral Agents - therapeutic use | Double-Blind Method | HIV Infections - virology | Anti-Retroviral Agents - adverse effects | Genotype | Treatment Outcome | CD4 Lymphocyte Count | HIV Fusion Inhibitors - adverse effects | HIV-1 - genetics | HIV Fusion Inhibitors - therapeutic use | HIV Infections - drug therapy | Transaminases - blood | Aged | Peptide Fragments - therapeutic use | Antiviral agents | Care and treatment | Maraviroc | Comparative analysis | Health aspects | HIV infection | Drug therapy | Drug resistance | Human immunodeficiency virus--HIV | Chemokines | Index Medicus | Abridged Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, pp. e98152 - e98152
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 08/2018, Volume 18, Issue 1, pp. 438 - 15
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 10/2019, Volume 38, Issue 10, pp. 1849 - 1856
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 07/2019, Volume 38, Issue 7, pp. 710 - 715
BACKGROUND:The need for antimicrobial therapies effective against multidrug resistant organisms for children remains unmet. Tigecycline shows antibacterial... 
INFECTIOUS DISEASES | pharmacokinetics | PEDIATRICS | IMMUNOLOGY | pharmacovigilance | real-world experience | EXPOSURE-RESPONSE ANALYSES | Clinical trials | Research | Drug resistance | Pediatric research | Analysis
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2012, Volume 56, Issue 5, pp. 2408 - 2413
Journal Article
Journal Article